Projects per year
- 1 - 50 out of 510 results
Search results
-
?Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response?
9/19/23 → 8/31/28
Project: Federal Funding Agencies
-
18F-MK-6240 Tau PET and Brain Inflammation in Alzheimer’s Disease
Masdeu, J. C., Faridar, A., Fujita, M., Nakawah, M. O., Pascual, B. & Roman, G. C.
10/29/19 → …
Project: Clinical Trial
-
4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
8/1/23 → 7/31/30
Project: Federal Funding Agencies
-
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
Kleiman, N., Faza, N., Goel, S., Little, S. H., Reardon, M. J. & Volpi, J. J.
9/9/19 → …
Project: Clinical Trial
-
-
Administrative supplement for rapid advancement of a safe and effective vaccine targeting Monkeypox
9/30/22 → 9/29/24
Project: Federal Funding Agencies
-
Advancing MRI Technology for Early Diagnosis of Liver Metastases
12/1/20 → 11/30/24
Project: Federal Funding Agencies
-
African trypanosome parasites: a new tool to unveil potential immunological strategies totarget CLL
5/3/21 → 4/30/24
Project: Federal Funding Agencies
-
A GMP/GLP investigation of degradable polymeric shells for traumatic osteoregeneration
Taraballi, F., Ihrig, M. & Weiner, B. K.
9/30/15 → 9/29/24
Project: Federal Funding Agencies
-
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
9/30/19 → 5/31/24
Project: Federal Funding Agencies
-
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer¿s Disease and Inter Amyloid (A3 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
6/1/19 → 4/30/24
Project: Federal Funding Agencies
-
-
-
-
-
-
-
-
AI-Based Characterization of Coronary Artery Disease with Coronary CT Angiogram C00242029
9/1/22 → 8/31/24
Project: Non Profit
-
ALLIANCE A221602: OLANZAPINEWITH ORWITHOUT FOSAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC): A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Darcourt, J., Bernicker, E. H., Chang, J. C., Geyer, C. E., Heyne, K. & Niravath, P. A.
3/6/20 → 3/5/45
Project: Non Profit
-
Alternative polyadenylation in heart failure
Amirthalingam Thandavarayan, R.
4/1/23 → 3/31/26
Project: Non Profit
-
-
Amplatzer Amulet LAAO vs. NOAC (CATALYST)
Valderrábano, M., Dave, A., Goel, S., Lador, A., Mathuria, N. & Schurmann, P. A.
4/19/21 → …
Project: Clinical Trial
-
A Multicenter, Prospective, Open-label, Randomized Controlled Clinical Trial to Compare the Safety and Effectiveness of the VitaSmartTM Liver Machine Perfusion System with Static Cold Storage for Organ Preservation Prior to Liver Transplantation
Saharia, A., Ghobrial, R. M., Hobeika, M. J. & Mobley, C. M.
5/16/22 → …
Project: Clinical Trial
-
A multi-center, randomized, 36-month, parallel group, non-inferiority, phase III study to compare the effectiveness of 500 mcg QD or alternate regimen of roflumilast (Daliresp) therapy versus 250 mg QD, 500 mg QD three times per week, or alternate regime
12/1/21 → 5/31/24
Project: Federal Funding Agencies
-
A multi-center, randomized, 36-month, parallel group, non-inferiority, phase III study to compare the effectiveness of 500 mcg QD or alternate regimen of roflumilast (Daliresp) therapy versus 250 mg QD, 500 mg QD three times per week, or alternate regime
12/1/21 → 5/31/24
Project: Federal Funding Agencies
-
A Multicenter, Registry Study of Avance® Nerve Graft Utilization, Evaluations and Outcomes in Peripheral Nerve Injury Repair
3/21/19 → …
Project: Clinical Trial
-
An African-American Family Story About Kidney Disease
Waterman, A. D. & Davis, L. A.
3/14/23 → …
Project: Clinical Trial
-
Anatomical Modeling to Improve the Precision of Image Guided Liver Ablation
Ensor, Jr., J. E. & Ensor, Jr., J. E.
9/1/19 → 8/31/24
Project: Federal Funding Agencies
-
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System
Goel, S., Faza, N., Kleiman, N., Little, S. H. & Reardon, M. J.
6/29/21 → …
Project: Clinical Trial
-
An Examination of the Gut Microbiome in Adults with Psychiatric Illness: A Longitudinal Perspective
Madan, A., Bourassa, K., Fowler, C. & Weinstein, B.
3/28/23 → …
Project: Clinical Trial
-
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
2/19/19 → …
Project: Clinical Trial
-
An Open-Label, Controlled, Randomized Phase 3 Trial Evaluating 12-Month Kidney Function in Highly Sensitized (cPRA =99.9%) Kidney Transplant Patients with Positive Crossmatch Against a Deceased Donor, Using Imlifidase with Standard of Care
Gaber, A. O., Knight, R. J. & Yi, S.
8/4/22 → …
Project: Clinical Trial
-
An Open-label, Multicenter Trial of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of M1774 in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
Singh, M., Abdelrahim, M., Heyne, K., Niravath, P. A. & Zhang, J.
7/25/22 → …
Project: Clinical Trial
-
An Open-Label Randomized Active-Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-ResistantOvarian Cancer
Kamat, A. A., Alaniz, A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.
3/15/21 → 3/14/46
Project: Non Profit
-
A novel hyper-immunogenic low virulent BCG vaccine against tuberculosis
2/3/23 → 1/31/28
Project: Federal Funding Agencies
-
A Novel Multi-Antigen Vaccine (TNBCvax) to Prevent Triple Negative Breast Cancer
9/16/21 → 8/15/24
Project: Federal Funding Agencies
-
A Novel Rapidly Deployable mRNA Vaccine Production Platform.
8/21/23 → 8/20/24
Project: Federal Funding Agencies
-
A novel tool in high- dimensional single-cell space to predict neurotoxicity of CAR T cell therapies
8/1/21 → 7/31/26
Project: Federal Funding Agencies
-
-
-
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of K0706 in Subjects With Early Parkinson's Disease
10/22/19 → …
Project: Clinical Trial